An upcoming report, to be published in Gut, detailed results of the blood test.
The test has 95 percent sensitivity and specificity in detecting celiac disease. The test looks for the blood levels of anti-transglutaminase antibodies. People with celiac disease have higher levels of these antibodies.
Before the blood test, patients would often wait up to a decade from the time they first confirmed symptoms to a celiac diagnosis because of the process involved. Physicians previously had to perform duodenal biopsies to diagnose celiac disease. This blood test eliminates the need for a biopsy.
More articles on surgery centers:
12-OR ASC part of $295M Florida orthopedic hospital expansion
3 ASCs launching total joint programs
4 ASCs installing total joint robots
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
